摘要
目的:观察益康唑/曲安奈德乳膏(派瑞松)和糠酸莫米松软膏(摩弥齐)治疗皮炎和湿疹的疗效。方法:72例患者分为两组,A组给予派瑞松,B组给予摩弥齐,均连用3周,初诊当日和用药第1、2、3周检查记录,评价疗效。结果:A组平均起效时间为3.1±1.0日,B组平均起效时间为2.9±1.1日,两组差异无显著性。A组第1、2、3周痊愈数、有效率均高于B组,但差异无显著性。两组均未出现明显不适,耐受性好。结论:派瑞松霜是一种良好的治疗皮炎湿疹的外用药,见效快,无明显刺激,无过敏反应,安全性好,使用方便,疗效显著,可广泛用于临床。
OBJECTIVE： To analyze the efficacy of budesonide/econazole （pevisone） vs. mometasone （momiqi ） for dermitis and eczema. METHODS： A total of 72 cases were randomly treated with pevisone （group A） or momiqi （group B） for 3 consecutive weeks. Clinical evaluation was performed based on the examination records on the first day of visiting, at 1, 2, and 3 weeks follow - up. RESULTS： The average response time was 3.1±1.0 days for group A and 2.9±1.1 days for group B, and there was no significant difference between two groups. The number of recovery cases and effective rates at 1, 2,and 3 weeks in group A were higher than in group B,but there was no significant difference between the two groups. No obvious discomfort appeared in either group, and both group had a good tolerance. CONCLUSION： Pevisone is a satisfactory external applied agent for dermatitis and eczema for its quick response, good safety, convenience in use, striking curative efficacy and it causes neither obvious irritation and nor allergic response, therefore, it can be used extensively in the clinic.
出处
《中国医院用药评价与分析》
2007年第4期297-298,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
